GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40120C00176THE LELAND STANFORD JUNIOR UNIVERSITY

Overview

Award facts

Net obligations
$3.96M
$3,956,154of $3.96M potential value
Outlays (paid to date)
$3.85M
$3.85M paid of $3.96M obligated$3,850,803
Period of performance
Sep 30, 2020 to Mar 30, 2026
Ended
Modifications
11
Latest action Sep 15, 2025
Contract type
Definitive contract
PIID 75F40120C00176

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

PATHOLOGY AND PATHOGENESIS OF CORONAVIRUS INFECTIONS IN ANIMAL MODELS

Dates and value

Award date
Signed on Sep 30, 2020
Potential end of performance
Mar 29, 2026
Current value
$3,956,154Base and exercised options
Potential value (if all options are exercised)
$3,956,154

Obligations by fiscal year of action

  • FY2024: $1,205,654
  • FY2023: $700,000
  • FY2021: $500,000
  • FY2020: $1,550,500

Total across 4 fiscal years: $3,956,154

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 15, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationSTANFORD, CA
UEIHJD6G4D6TJY5
CAGE code1KN27
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationEducational institutionTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Foods; Human drugs; Devices and radiological health; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Coronavirus emergency funding supplementalProgram activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0001
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
10

Solicitation and notices

Solicitation ID
FDABAA-20-00123
Solicitation date
Sep 25, 2020
Notices

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 30, 2020Base obligation at award: $1,550,500
Latest action
Sep 15, 2025 — Other administrative actionModification P00011; administrative: no change in scope or value
Latest substantive action
Aug 19, 2024 — Supplemental agreement (within scope)Modification P00009; obligation change +$1,205,654
Actions by type
  • Base award1
  • Other administrative action6
  • Supplemental agreement (within scope)5
12 actions recorded, Sep 30, 2020 to Sep 15, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Closely associated,critical functionsCL,CT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
12

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2020/2020-0600-000
  • 075-2023/2023-0600-000
  • 075-2024/2024-0600-000
  • 075-X-0600-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • U: Emergency P.L. 116-260
COVID-19 supplemental obligations
$2,378,037
COVID-19 supplemental outlays
$2,372,872